Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...